Real-world data on long-acting intramuscular maintenance therapy with cabotegravir and rilpivirine mirror Phase 3 results.

Alexandra SerrisValentine Marie FerreQuentin Le HingratAntoine BachelardCharlotte CharpentierMarina ExarchopoulosFlorence DamondBao-Chau PhungRoland LandmanYazdan YazdanpanahDiane DescampsVéronique JolyGilles Peytavin Jade Ghosn

Published in: The Journal of antimicrobial chemotherapy (2024)

Data from this real-world cohort of PLHIV who received cabotegravir/rilpivirine LA injections suggest that this regimen is effective and well tolerated. Virological failures were not associated with the acquisition of resistance mutations.

Keyphrases

hiv infected patients
electronic health record
big data
antiretroviral therapy
stem cells
platelet rich plasma
bone marrow
cell therapy